Skip to main content
OCSLOaktree Specialty Lending CorpoHold5.9·$11.80
HoldModerate Confidence
Investment thesis

Oaktree Specialty Lending trades attractively cheap with a solid earnings beat streak, but declining revenue and a negative free-cash-flow earnings-quality flag raise value-trap concerns after the stock already reached its analyst target.

Thesis pillars

  • Attractive Valuation Earnings Beat→Stable
  • Negative Fcf Earnings Quality Flag→Stable
  • Revenue Decline Value Trap Signal↓Deteriorating
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 5, 2026, based on the 10-K filed Nov 18, 2025

Full reasoning →

Open full analysis

Oaktree Specialty Lending Corpo (OCSL) Stock Analysis

Catalyst-Driven edge

HoldVALUE-TRAP 1/5ValueGrowthShortModerate Confidence

Financial Services · Asset Management

Hold if already holding. Not a fresh buy at $11.80, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5.

Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions,... Read more

$11.80-7.8% A.UpsideScore 5.9/10#75 of 229 Asset Management
QualityF-score7 / 9FCF yield8.60%
IncomeYield11.18%(5y avg 11.14%)Payout320.83%at-risk
Stop $11.32Analyst target $10.88(reached)A.R:R -1.5:1
Analyst consensus$12.50+5.9%6 analysts
$11.80price
$12.50mean
$12
$14

Hold if already holding. Not a fresh buy at $11.80, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 5.9/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 18d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Nov 17, 202618d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Financial Services): +1.0
Strong earnings beat streak (4/4)
Attractive valuation
Risks
Analyst target reached - limited upside remaining
Leverage penalty (D/E 1.0): -0.5

Key Metrics

P/E (TTM)24.6
P/E (Fwd)8.7
Mkt Cap$1.0B
EV/EBITDA—
Profit Mgn14.5%
ROE3.0%
Rev Growth-7.8%
Beta0.58
Dividend11.18%
Rating analysts12

Quality Signals

Piotroski F7/9

Options Flow

P/C2.14bearish
IV58%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
1.7
Growth Rank
2.0
Value Rank
4.6
GatesA.R:R -1.5=NEGATIVEMomentum 6.7>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 18d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
50 · Neutral
↑ 20D MA↓ 50D MA↑ 200D MAGOLDEN CROSSSupport $11.19Resistance $12.11

Price Targets

A.Upside-7.8%
A.R:R-1.5:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (-7.8% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-11-17 (18d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is OCSL stock a buy right now?

Hold if already holding. Not a fresh buy at $11.80, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Analyst target $10.88 reached (−7.8%), stop $11.32 (−4.2%), A.R:R -1.5:1. Score 5.9/10, moderate confidence.

What is the OCSL stock price target?

Analyst target $10.88 reached (−7.8% from $11.80); no take-profit level is published. Analyst target $10.88 reached (−7.8%), stop $11.32 (−4.2%), A.R:R -1.5:1. Stop-loss: $11.32.

What are the risks of investing in OCSL?

Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5.

Is OCSL overvalued or undervalued?

Oaktree Specialty Lending Corpo trades at a P/E of 24.6 (forward 8.7). TrendMatrix value score: 7.3/10. Verdict: Hold.

What do analysts say about OCSL?

12 analysts cover OCSL with a consensus score of 2.6/5. Average price target: $13.

What does Oaktree Specialty Lending Corpo do?Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle...

Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.

Related stocks: GAB (Gabelli Equity Trust, Inc. (The) · HLNE (Hamilton Lane Incorporated) · CII (BlackRock Enhanced Large Cap Co) · TWN (Taiwan Fund, Inc. (The)) · FFA (First Trust Enhanced Equity Inc)
Home › Stocks › OCSL

Latest news

Latest News

MarketBeat92d agoEarnings
TradingKey92d ago
TradingKey93d ago
Yahoo Finance86d agoEarnings
Investing.com86d agoEarnings
TipRanks86d agoEarnings
MarketBeat89d agoAnalyst
TipRanks87d agoEarnings
TipRanks87d agoEarnings
TradingKey90d ago
Fiscal.ai2d ago
Benzinga3d ago
Fiscal.ai10d agoEarnings
Benzinga50d ago
Benzinga85d ago